XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total NantHealth Stockholders' Deficit
Total NantHealth Stockholders' Deficit
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020         111,284,733            
Beginning balance at Dec. 31, 2020 $ (111,400) $ (5,746) $ (111,784) $ (5,746) $ 11 $ 891,583 $ (14,318) $ (1,003,210) $ 8,572 $ (168) $ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation cost 912   912     912          
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)         81,400            
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes 64   64     64          
Other comprehensive loss 28   28             28  
Net loss (15,499)   (15,408)         (15,408)     (91)
Ending balance (in shares) at Mar. 31, 2021         111,366,133            
Ending balance at Mar. 31, 2021 (131,641)   (131,934)   $ 11 878,241   (1,010,046)   (140) 293
Beginning balance (in shares) at Dec. 31, 2020         111,284,733            
Beginning balance at Dec. 31, 2020 (111,400) $ (5,746) (111,784) $ (5,746) $ 11 891,583 $ (14,318) (1,003,210) $ 8,572 (168) 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Other comprehensive loss 46                    
Net loss (30,930)                    
Ending balance (in shares) at Jun. 30, 2021         115,204,656            
Ending balance at Jun. 30, 2021 (136,105)   (136,270)   $ 12 889,189   (1,025,349)   (122) 165
Beginning balance (in shares) at Mar. 31, 2021         111,366,133            
Beginning balance at Mar. 31, 2021 (131,641)   (131,934)   $ 11 878,241   (1,010,046)   (140) 293
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation cost 887   887     887          
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)         222,553            
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes 61   61     61          
Stock issued on Exchange of 2016 Notes (in shares)         3,615,970            
Stock issued on Exchange of 2016 Notes 10,001   10,001   $ 1 10,000          
Other comprehensive loss 18   18             18  
Net loss (15,431)   (15,303)         (15,303)     (128)
Ending balance (in shares) at Jun. 30, 2021         115,204,656            
Ending balance at Jun. 30, 2021 (136,105)   (136,270)   $ 12 889,189   (1,025,349)   (122) 165
Beginning balance (in shares) at Dec. 31, 2021         115,505,244            
Beginning balance at Dec. 31, 2021 (161,992)   (161,992)   $ 12 891,105   (1,052,897)   (212) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation cost 1,417   1,417     1,417          
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes (in shares)         45,000            
Shares issued in connection with employee stock plans, net of shares withheld for employee taxes 24   24     24          
Other comprehensive loss (96)   (96)             (96)  
Net loss (15,950)   (15,950)         (15,950)      
Ending balance (in shares) at Mar. 31, 2022         115,550,244            
Ending balance at Mar. 31, 2022 (176,597)   (176,597)   $ 12 892,546   (1,068,847)   (308) 0
Beginning balance (in shares) at Dec. 31, 2021         115,505,244            
Beginning balance at Dec. 31, 2021 (161,992)   (161,992)   $ 12 891,105   (1,052,897)   (212) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Other comprehensive loss (374)                    
Net loss (28,462)                    
Ending balance (in shares) at Jun. 30, 2022         115,550,244            
Ending balance at Jun. 30, 2022 (188,098)   (188,098)   $ 12 893,835   (1,081,359)   (586) 0
Beginning balance (in shares) at Mar. 31, 2022         115,550,244            
Beginning balance at Mar. 31, 2022 (176,597)   (176,597)   $ 12 892,546   (1,068,847)   (308) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation cost 1,289   1,289     1,289          
Other comprehensive loss (278)   (278)             (278)  
Net loss (12,512)   (12,512)         (12,512)      
Ending balance (in shares) at Jun. 30, 2022         115,550,244            
Ending balance at Jun. 30, 2022 $ (188,098)   $ (188,098)   $ 12 $ 893,835   $ (1,081,359)   $ (586) $ 0